1. Home
  2. QTTB vs PSBD Comparison

QTTB vs PSBD Comparison

Compare QTTB & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.51

Market Cap

265.2M

Sector

Health Care

ML Signal

N/A

Logo Palmer Square Capital BDC Inc.

PSBD

Palmer Square Capital BDC Inc.

N/A

Current Price

$9.63

Market Cap

318.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
PSBD
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.2M
318.2M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
QTTB
PSBD
Price
$8.51
$9.63
Analyst Decision
Strong Buy
Hold
Analyst Count
7
6
Target Price
★ $39.67
$10.46
AVG Volume (30 Days)
★ 322.9K
114.3K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
★ 15.51%
EPS Growth
★ 136.78
N/A
EPS
N/A
★ 1.66
Revenue
★ $53,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.78
Revenue Growth
N/A
N/A
52 Week Low
$1.93
$9.34
52 Week High
$23.57
$12.45

Technical Indicators

Market Signals
Indicator
QTTB
PSBD
Relative Strength Index (RSI) 41.77 40.30
Support Level $8.23 $9.38
Resistance Level $9.41 $10.22
Average True Range (ATR) 0.54 0.23
MACD -0.01 -0.03
Stochastic Oscillator 20.24 13.89

Price Performance

Historical Comparison
QTTB
PSBD

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: